Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy.

Date publication

juin 2015

Journal

American journal of clinical oncology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MERROUCHE Yacine

Tous les auteurs :
Pacaut C, Bourmaud A, Rivoirard R, Moriceau G, Guy JB, Collard O, Bosacki C, Jacquin JP, Levy A, Chauleur C, Magné N, Merrouche Y

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/23751320

Résumé

The aim of this study was to assess the outcome and the prognosis factors of uterine and ovarian carcinosarcomas.

Mots clés

Adult, Aged, Aged, 80 and over, Carcinosarcoma, mortality, Chemoradiotherapy, Adjuvant, Chemotherapy, Adjuvant, Disease-Free Survival, Female, Follow-Up Studies, Humans, Hysterectomy, Lymph Node Excision, Middle Aged, Neoplasm Staging, Ovarian Neoplasms, mortality, Ovariectomy, Radiotherapy, Adjuvant, Retrospective Studies, Salpingectomy, Survival Rate, Treatment Outcome, Uterine Neoplasms, mortality

Référence

Am. J. Clin. Oncol.. 2015 Jun;38(3):272-7